ID23179A - PROSES UNTUK MEMPRODUKSI OBAT-OBATAN YANG MENGANDUNG PENGHAMBAT HMG KoA REDUKTASE - Google Patents

PROSES UNTUK MEMPRODUKSI OBAT-OBATAN YANG MENGANDUNG PENGHAMBAT HMG KoA REDUKTASE

Info

Publication number
ID23179A
ID23179A IDW991494A ID991494A ID23179A ID 23179 A ID23179 A ID 23179A ID W991494 A IDW991494 A ID W991494A ID 991494 A ID991494 A ID 991494A ID 23179 A ID23179 A ID 23179A
Authority
ID
Indonesia
Prior art keywords
reducers
hmg coa
producing drugs
contain
contain hmg
Prior art date
Application number
IDW991494A
Other languages
English (en)
Indonesian (id)
Inventor
Fritz Schuckler
Karl Geisen
Norbert Pollinger
Samir Samaan
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ID23179A publication Critical patent/ID23179A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IDW991494A 1997-06-16 1998-06-03 PROSES UNTUK MEMPRODUKSI OBAT-OBATAN YANG MENGANDUNG PENGHAMBAT HMG KoA REDUKTASE ID23179A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19725391A DE19725391A1 (de) 1997-06-16 1997-06-16 Verfahren zur Herstellung von Arzneimittel, enthaltend HMG-CoA-Reduktase-Inhibitoren

Publications (1)

Publication Number Publication Date
ID23179A true ID23179A (id) 2000-03-23

Family

ID=7832616

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991494A ID23179A (id) 1997-06-16 1998-06-03 PROSES UNTUK MEMPRODUKSI OBAT-OBATAN YANG MENGANDUNG PENGHAMBAT HMG KoA REDUKTASE

Country Status (23)

Country Link
US (2) US20020146454A1 (es)
EP (1) EP0991616B1 (es)
JP (1) JP2002504126A (es)
KR (1) KR20010013792A (es)
CN (1) CN1260774A (es)
AR (1) AR012963A1 (es)
AT (1) ATE240925T1 (es)
AU (1) AU734787B2 (es)
BG (1) BG103931A (es)
BR (1) BR9810129A (es)
CA (1) CA2294724A1 (es)
DE (2) DE19725391A1 (es)
ES (1) ES2198728T3 (es)
HU (1) HUP0002720A3 (es)
ID (1) ID23179A (es)
IL (1) IL132987A0 (es)
NO (1) NO996183L (es)
NZ (1) NZ501760A (es)
PL (1) PL337343A1 (es)
SK (1) SK171199A3 (es)
TR (1) TR199902871T2 (es)
WO (1) WO1998057917A1 (es)
ZA (1) ZA985179B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE44578E1 (en) 2000-04-10 2013-11-05 Teva Pharmaceutical Industries, Ltd. Stable pharmaceutical compositions containing 7-substituted-3,5-dihydroxyheptanoic acids or 7-substituted-3,5-dihydroxyheptenoic acids
CA2406574C (en) * 2000-04-10 2006-12-05 Teva Pharmaceutical Industries, Ltd. Stable pharmaceutical compositions containing 7-substituted-3,5-dihydroxyheptanoic acids or 7-substituted-3,5-dihydroxyheptenoic acids
EP1810667A1 (en) * 2006-01-20 2007-07-25 KRKA, tovarna zdravil, d.d., Novo mesto Pharmaceutical composition comprising amorphous atorvastatin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU9203780D0 (en) * 1991-12-12 1993-03-29 Sandoz Ag Stabilized pharmaceutical products of hmg-coa reductase inhibitor and method for producing them
ES2133158T3 (es) * 1993-01-19 1999-09-01 Warner Lambert Co Formulacion ci-981 oral, estable y proceso de preparacion del mismo.

Also Published As

Publication number Publication date
AU8335398A (en) 1999-01-04
NO996183D0 (no) 1999-12-14
HUP0002720A3 (en) 2001-12-28
HUP0002720A2 (hu) 2000-12-28
US20020146454A1 (en) 2002-10-10
BG103931A (en) 2000-07-31
NZ501760A (en) 2001-05-25
AR012963A1 (es) 2000-11-22
US20030203964A1 (en) 2003-10-30
IL132987A0 (en) 2001-03-19
ES2198728T3 (es) 2004-02-01
CA2294724A1 (en) 1998-12-23
PL337343A1 (en) 2000-08-14
NO996183L (no) 1999-12-14
KR20010013792A (ko) 2001-02-26
DE59808476D1 (de) 2003-06-26
CN1260774A (zh) 2000-07-19
JP2002504126A (ja) 2002-02-05
EP0991616B1 (de) 2003-05-21
BR9810129A (pt) 2000-08-08
SK171199A3 (en) 2000-07-11
AU734787B2 (en) 2001-06-21
DE19725391A1 (de) 1998-12-17
ZA985179B (en) 1999-01-08
TR199902871T2 (xx) 2000-02-21
EP0991616A1 (de) 2000-04-12
WO1998057917A1 (de) 1998-12-23
ATE240925T1 (de) 2003-06-15

Similar Documents

Publication Publication Date Title
ID24323A (id) Proses hidrosianasi yang tertingkatkan
HU9603484D0 (en) Pharmaceutical compositions and process for producing symptom-transduction
GR3031304T3 (en) 6-Dimethylaminomethyl-1-phenyl-cyclo-hexane compounds as pharmaceutical agents
ID26207A (id) ESTRATRIENA TERSUBSTITUSI 11β-HALOGEN-7 αTERSUBSTITUTASI, PROSES UNTUK MEMPRODUKSI SEDIAAN FARMASI YANG MENGANDUNG ESTRATRIENA 11β-HALOGEN-7 αINI DAN JUGA PENGGUNAANNYA UNTUK PRODUKSI ZAT-ZAT FARMASI
HUP9603112A3 (en) New pharmaceutical formulation and process for its production
TR199600792A2 (tr) Dihaloazolopirimidinlerin hazirlanmasina yönelik proses.
AUPN605795A0 (en) Analgesic pharmaceutical composition
HUP9900052A3 (en) Pharmaceutical pellet formulation and process for producing it
ID22641A (id) Proses pembuatan e-kaprolaktam
ID21845A (id) Proses pengolahan benda-benda selulosa yang dicetak
ID20274A (id) Proses untuk memproduksi diamina
HUP9801409A3 (en) Tetrahydroisoquinolin derivative as apo b-secretion or/and mtp inhibitor, process for producing it and pharmaceutical composition containing it
ID26580A (id) Proses untuk memproduksi produk-produk pektin yang difraksionasi
HU9802180D0 (en) Process for producing pharmaceutical compositions
ZA964129B (en) N-acyl-2-aryl cyclopropylmethylamine derivatives as melatonerigics
GR3033414T3 (en) N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
IL117397A0 (en) Novel naphthyl pharmaceutical compounds
ID20685A (id) Sediaan-sediaan farmasi silansetron yang distabilkan terhadap rasemisasi
ID24830A (id) Proses untuk pengolahan laktam
ID24527A (id) Proses pembuatan senyawa-senyawa farmasi
HUP9902559D0 (en) Pharmaceutical composition and process for producing it
ID25830A (id) Proses pembuatan turunan-n laktam yang ditingkatkan secara enasiomer
ID22430A (id) Proses pembuatan senyawa-senyawa benzotiazolona
ID20458A (id) Proses untuk memproduksi pupuk
ID24733A (id) Proses pembuatan paroksetin hidroklorida